246
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Concanavalin A-conjugated poly(ethylene glycol)–poly(lactic acid) nanoparticles for intranasal drug delivery to the cervical lymph nodes

, , , , , , , , & show all
Pages 780-786 | Received 19 Sep 2012, Accepted 11 Mar 2013, Published online: 30 Apr 2013

References

  • Akagi T, Kawamura M, Ueno M, Hiraishi K, Adachi M, Serizawa T, Akashi M, Baba M. Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice. J Med Virol, 2003;69:163–72
  • Akashi M, Niikawa T, Serizawa T, Hayakawa T, Baba M. Capture of HIV-1 gp120 and virions by lectin-immobilized polystyrene nanospheres. Bioconjug Chem, 1998;9:50–3
  • Bogenrieder T, Herlyn M. Axis of evil: Molecular mechanisms of cancer metastasis. Oncogene, 2003;22:6524–36
  • Chen J, Zhang C, Liu Q, Shao X, Feng C, Shen Y, Zhang Q, Jiang X. Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: In vivo and in vitro evaluations. J Drug Target, 2012;20:174–84
  • Csaba N, Garcia-Fuentes M, Alonso MJ. Nanoparticles for nasal vaccination. Adv Drug Deliv Rev, 2009;61:140–57
  • Davis SS. Nasal vaccines. Adv Drug Deliv Rev, 2001;51:21–42
  • Gao X, Tao W, Lu W, Zhang Q, Zhang Y, Jiang X, Fu S. Lectin-conjugated PEG-PLA nanoparticles: Preparation and brain delivery after intranasal administration. Biomaterials, 2006;27:3482–90
  • Gao X, Wu B, Zhang Q, Chen J, Zhu J, Zhang W, Rong Z, Chen H, Jiang X. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration. J Control Release, 2007;121:156–67
  • Giannasca PJ, Boden JA, Monath TP. Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins. Infect Immun, 1997;65:4288–98
  • Hamaguchi S, Tohnai I, Ito A, Mitsudo K, Shigetomi T, Ito M, Honda H, Kobayashi T, Ueda M. Selective hyperthermia using magnetoliposomes to target cervical lymph node metastasis in a rabbit tongue tumor model. Cancer Sci, 2003;94:834–9
  • Hanahan D, Weinberg RA. The hallmarks of cancer. Cell, 2000;100:57–70
  • Hawley AE, Illum L, Davis SS. Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res, 1997;14:657–61
  • Kang ML, Cho CS, Yoo HS. Application of chitosan microspheres for nasal delivery of vaccines. Biotechnol Adv, 2009;27:857–65
  • Khopade AJ, Nandakumar KS, Jain NK. Lectin-functionalized multiple emulsions for improved cancer therapy. J Drug Target, 1998;6:285–92
  • Kuper CF, Koornstra PJ, Hameleers DM, Biewenga J, Spit BJ, Duijvestijn AM, van Breda Vriesman PJ, Sminia T. The role of nasopharyngeal lymphoid tissue. Immunol Today, 1992;13:219–24
  • Lehr CM. Lectin-mediated drug delivery: the second generation of bioadhesives. J Control Release, 2000;65:19–29
  • Liu Q, Shao X, Chen J, Shen Y, Feng C, Gao X, Zhao Y, Li J, Zhang Q, Jiang X. In vivo toxicity and immunogenicity of wheat germ agglutinin conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal delivery to the brain. Toxicol Appl Pharmacol, 2011;251:79–84
  • Mo Y, Lim LY. Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells. J Pharm Sci, 2004;93:20–8
  • Nakamura S, Okochi K, Kurabayashi T. Dual-time-point fluorodeoxyglucose positron emission tomography for diagnosis of cervical lymph node metastases in patients with head and neck squamous cell carcinoma. J Comput Assist Tomogr, 2011;35:303–7
  • Pusztai A, Ewen SW, Grant G, Peumans WJ, Van Damme EJ, Coates ME, Bardocz S. Lectins and also bacteria modify the glycosylation of gut surface receptors in the rat. Glycoconj J, 1995;12:22–35
  • Ríos-Martin JJ, Díaz-Cano SJ, Rivera-Hueto F. Ultrastructural distribution of lectin-binding sites on gastric superficial mucus-secreting epithelial cells. The role of Golgi apparatus in the initial glycosylation. Histochemistry, 1993;99:181–9
  • Ross TM, Martinez PM, Renner JC, Thorne RG, Hanson LR, Frey WH II. Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis. J Neuroimmunol, 2004;151:66–77
  • Russell-Jones GJ, Veitch H, Arthur L. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int J Pharm, 1999;190:165–74
  • Shen Y, Chen J, Liu Q, Feng C, Gao X, Wang L, Zhang Q, Jiang X. Effect of wheat germ agglutinin density on cellular uptake and toxicity of wheat germ agglutinin conjugated PEG-PLA nanoparticles in Calu-3 cells. Int J Pharm, 2011;413:184–93
  • Tobío M, Gref R, Sánchez A, Langer R, Alonso MJ. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm Res, 1998;15:270–5
  • Wang Y, Ow TJ, Myers JN. Pathways for cervical metastasis in malignant neoplasms of the head and neck region. Clin Anat, 2012;25:54–71
  • Witschi C, Mrsny RJ. In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery. Pharm Res, 1999;16:382–90
  • Yang K, Wen Y, Wang C. The study of cucurbitacin BE polylactic acid nanoparticles delivering cucurbitacin BE to metastasized cervical lymph nodes in mice with oral cancer. Hua Xi Kou Qiang Yi Xue Za Zhi, 2003;21:477–80
  • Yi SM, Harson RE, Zabner J, Welsh MJ. Lectin binding and endocytosis at the apical surface of human airway epithelia. Gene Ther, 2001;8:1826–32

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.